RECITALSDistribution Agreement • November 18th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.1 (Date) (Name) (Address) Dear __________: The purpose of this letter agreement is to document the terms of the severance package to which you will be entitled should your employment with Ligand Pharmaceuticals Incorporated (the "Company")...Severance Agreement • August 30th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 2.1 AMENDMENT NUMBER 2 TO PURCHASE AGREEMENT THIS AMENDMENT NUMBER 2 TO PURCHASE AGREEMENT, (this "AMENDMENT") entered into and effective this the 26th day of February, 2007 (the "EFFECTIVE DATE OF THIS AMENDMENT"), is made by and between...Purchase Agreement • February 28th, 2007 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
by and amongStockholders Agreement • December 5th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Exhibit 2.3 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 15th, 2000 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
SETTLEMENT AGREEMENT, LICENSE AND MUTUAL GENERAL RELEASE This Settlement Agreement and Mutual General Release (the "Agreement"), having an effective date for all purposes of August 23, 1995, is made and entered into by and between La Jolla Cancer...Settlement Agreement • May 15th, 1997 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 1.1 $135,000,000 Principal Amount Ligand Pharmaceuticals Incorporated 6% Convertible Subordinated Notes due 2007 PURCHASE AGREEMENT PURCHASE AGREEMENTPurchase Agreement • January 13th, 2003 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
EX-1.1 OTHERDOC 2 0002.txt JOINT FILING AGREEMENTJoint Filing Agreement • November 29th, 2002 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
The undersigned hereby agree that the Statement on this Schedule 13G, dated November 29, 2002, (the "Schedule 13G"), with respect to the Common Stock, par value $0.001 per share, of Ligand Pharmaceuticals Incorporated is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
EXHIBIT 10.237 LIGAND PHARMACEUTICALS INCORPORATED STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (the "Agreement") is made as of the 5th day of January, 2001, by and between Ligand Pharmaceuticals Incorporated (the "Company"), a corporation...Stock Purchase Agreement • May 7th, 2001 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
3 4 not misleading and (ii), in the case of the Prospectus, in light of the circumstances under which they were made, not misleading. When any related preliminary prospectus was first filed with the Commission (whether filed as part of the...Underwriting Agreement • October 22nd, 1996 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
ESCROW AGREEMENTEscrow Agreement • July 9th, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
EXHIBIT 4.5 PLEDGE AGREEMENT This PLEDGE AGREEMENT (this "PLEDGE AGREEMENT") is made and entered into as of November 26, 2002 by and between LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (the "PLEDGOR"), and J.P. MORGAN TRUST COMPANY,...Pledge Agreement • January 13th, 2003 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT Dated as of October 12, 2023 among LIGAND PHARMACEUTICALS INCORPORATED, as the Borrower, THE SUBSIDIARIES OF THE BORROWER PARTY HERETO, as the Guarantors, CITIBANK, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and...Credit Agreement • October 18th, 2023 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CREDIT AGREEMENT is entered into as of October 12, 2023, among Ligand Pharmaceuticals Incorporated, a Delaware corporation (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein), and CITIBANK, N.A., as Administrative Agent, Swingline Lender and L/C Issuer.
EXHIBIT 10.13 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT is made as of the 30th day of September, 1999, by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation (the "Company"), and Elan International Services, Ltd., a...Stock Purchase Agreement • November 15th, 1999 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
LOCK-UP AGREEMENTLock-Up Agreement • December 9th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
LIGAND PHARMACEUTICALS INCORPORATED AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 22, 2018Indenture • May 22nd, 2018 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of May 22, 2018, between LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01) and WILMINGTON TRUST, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
EXHIBIT 10.2 [LIGAND LETTERHEAD} 8 December 2005 Tod Mertes 608 The Strand Oceanside, CA 92054 Dear Tod: The purpose of this letter agreement is to document 1) the terms of a severance package to which you will be entitled should your employment with...Severance Agreement • December 14th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 99.3Stock Option Agreement • June 28th, 2002 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
Sales AgreementSales Agreement • March 26th, 2012 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
Ligand Pharmaceuticals Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
1 EXHIBIT 10.150 [USL CAPITAL LOGO] MASTER LEASE AGREEMENT [FORD FINANCIAL LOGO]Master Lease Agreement • March 31st, 1997 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.217 No. X-1 NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE HEREUNDER HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED IN THE ABSENCE OF AN...Warrant Agreement • March 29th, 2000 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
Exhibit 10.259 AMENDMENT NO. 2 TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDMENT NO. 2 TO AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made on the 25th day of June, 2003, by and among Ligand...Registration Rights Agreement • August 13th, 2003 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
ARTICLE 1 DEFINITIONSManufacturing Agreement • May 7th, 2004 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
BETWEENPurchase Agreement • March 21st, 2003 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.235 DISTRIBUTORSHIP AGREEMENT THIS DISTRIBUTORSHIP AGREEMENT ("Agreement"), is entered into as of February 28, 2001 between: LIGAND PHARMACEUTICALS INCORPORATED, a corporation organized and existing under the laws of the State of Delaware,...Distributor Agreement • May 7th, 2001 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • England
1 EXHIBIT 10.168 COLLABORATION AGREEMENTCollaboration Agreement • March 31st, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Indiana
RECITALSLicense Agreement • November 15th, 1999 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
ADOPTION AGREEMENT FOR SMITH BARNEY INC. EXECCHOICE(R) NONQUALIFIED DEFERRED COMPENSATION PLANAdoption Agreement • May 7th, 2004 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.246 AMENDED AND RESTATED LICENSE AGREEMENT BETWEEN THE SALK INSTITUTE FOR BIOLOGICAL STUDIES AND LIGAND PHARMACEUTICALS INCORPORATEDLicense Agreement • August 14th, 2002 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.289 LIGAND PHARMACEUTICALS INCORPORATED STOCK ISSUANCE AGREEMENT This STOCK ISSUANCE AGREEMENT is made this _____ day of ______________, 200__ (the "Grant Date"), by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation,...Stock Issuance Agreement • January 13th, 2006 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
RECITALSRegistration Rights Agreement • March 29th, 2000 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.269 LIGAND PHARMACEUTICALS INCORPORATED STOCK OPTION AGREEMENT RECITALS A. The Board has adopted the Plan for the purpose of retaining the services of selected Employees, non-employee members of the Board (or the board of directors of any...Stock Option Agreement • March 12th, 2004 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
AMENDMENT TO AGREEMENT AMONG LIGAND PHARMACEUTICALS INCORPORATED, SERAGEN, INC. AND ELI LILLY & COMPANYAmendment to Agreement • November 18th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Indiana
EXHIBIT 10.278 October 1, 2004 Eric S. Groves, M.D., Ph.D. Vice-President, Project Management Ligand Pharmaceuticals Incorporated 10275 Science Center Drive San Diego, CA 92121 Dear Eric: The purpose of this letter agreement is to document the terms...Severance Agreement • November 18th, 2005 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
1 EXHIBIT 10.167 DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • March 31st, 1998 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • Indiana
